Introducing
An Ambulatory Bi-atrial Pressure (BAP) Monitor
Key Advantages
Physician Benefits
- Bi-atrial pressure for better drug titration (diuresis + vasodilation)
- Left and right atrial 'differential' pressure to evaluate inter-atrial shunt placement
- Ambulatory data that provides AF, Sleep Apnea and MR/TR diagnosis
- AI powered summary for faster data analysis and decision making
- Bidirectional communication with patients
Patient Benefits
- Get longer and better quality of life
- Automatic data measurement and uploads (no need to manually upload 2-3x a day)
- Interactive home monitor for greater engagement
- >10 year battery life (internally powered)
- Bidirectional communication with doctor
Team
Suresh Gurunathan
Co-founder and CEO
- 25+ years in class III medical device industry
- Program director at Abbott
- Software Architect of world's first Dual Chamber Leadless pacemaker (Nanostim/Aveir) at Abbott
- Part of team that developed the RNS neurostimulator for epilepsy at NeuroPace
Frank Fischer
Chairman of the board
- President and CEO of Neuropace, Heartport and Ventritex
- Chairman of the board at Neuropace.
- Member of Board of Directors at Nevro, Tenon Medical and Mindtrace
- Member of Board of trustees at Rensselaer Polytechnic Institute and Babson College.
Alan Ostroff
Co-founder and CTO
- Co-founder of Nine Continents Medical,
acquired by Coloplast in 2020 for $145M - Co-founder of Nanostim, acquired by
St Jude Medical in 2013 for $123.5 - MVP of Engineering at Cameron Health
- Over 75 patents in the field of active implantable devices
Want more information or set up a meeting? Get in contact with us.